| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 11/16/2010 | CA2515918C Uv stable transdermal therapeutic plaster |
| 11/16/2010 | CA2430897C Liposomal composition comprising water-soluble corticosteroids for the treatment of inflammatory disorders |
| 11/16/2010 | CA2429205C Dermatological formulations |
| 11/16/2010 | CA2415643C Pharmaceutical composition for oral use with improved absorption |
| 11/16/2010 | CA2402278C Diabetic nutritionals |
| 11/16/2010 | CA2398901C Methods and compositions for treating conditions of the eye |
| 11/16/2010 | CA2337361C Targeted site specific drug delivery compositions and method of use |
| 11/16/2010 | CA2333578C Adjuvant and vaccine compositions containing monophosphoryl lipid a |
| 11/16/2010 | CA2330659C Using ngali nut oil to treat/relieve manifestations of arthritis and other similar conditions |
| 11/16/2010 | CA2277878C Rapid sloughing tablets |
| 11/16/2010 | CA2240339C [3'-desoxy-3'-oxo-mebmt]1-[val]2-ciclosporin-containing emulsion pharmaceutical composition |
| 11/16/2010 | CA2237159C Glycosaminoglycan-antithrombin iii/heparin cofactor ii conjugates |
| 11/16/2010 | CA2215529C Carbohydrate-based vaccine and diagnostic reagent for trichinosis |
| 11/11/2010 | WO2010129819A2 Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| 11/11/2010 | WO2010129570A1 Solid forms of sulfonamides and amino acids |
| 11/11/2010 | WO2010129545A2 Porous silicon drug-eluting particles |
| 11/11/2010 | WO2010128983A1 Topical solution formulations containing a corticosteroid and a cyclodextrin |
| 11/11/2010 | WO2010128793A2 Fat soluble vitamin and a derivative thereof induced by novel cationic chitosan, a method of producing same and drug delivery system containing same |
| 11/11/2010 | WO2010128669A1 Gene transfer agent composition containing polyamidoamine dendron |
| 11/11/2010 | WO2010128601A1 Glucuronic acid-containing glucan, process for production of same, and use of same |
| 11/11/2010 | WO2010128303A1 Multi- valent adjuvant display |
| 11/11/2010 | WO2010128300A1 Composition for sustained drug delivery comprising geopolymeric binder |
| 11/11/2010 | WO2010128141A1 Stable pharmaceutical compositions of peptide derivatized using an oxime linker |
| 11/11/2010 | WO2010128111A1 Concentrated mast cell stabilizing pharmaceutical formulations |
| 11/11/2010 | WO2010128087A2 Uses of immunoconjugates targeting cd138 |
| 11/11/2010 | WO2010127647A1 Compositions for wound treatment in the human and veterinary field |
| 11/11/2010 | WO2010107342A3 Agent and method for washing down solid dosage forms |
| 11/11/2010 | WO2010086880A3 A medical device loaded with formulations for targeted delivery of biologically active material/s and method of manufacture thereof |
| 11/11/2010 | WO2010086129A8 Inclusion complex comprising cinacalcet and cyclodextrin |
| 11/11/2010 | WO2010064258A3 Pharmaceutical formulations of pegylated interferon |
| 11/11/2010 | WO2008148080A8 Pharmaceutical compositions of [5(s)-(2'-hydroxyethoxy)-20(s)-camptothecin] |
| 11/11/2010 | WO2008122039A9 Selenocysteine mediated hybrid antibody molecules |
| 11/11/2010 | WO2004062646A9 Stabilized lyophilized compositions comprising tissue factor pathway inhibitor or tissue factor pathway inhibitor variants |
| 11/11/2010 | US20100286583 Non-Woven Fabric |
| 11/11/2010 | US20100286367 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 11/11/2010 | US20100286291 Multiplex detection of hepatitis virus variations |
| 11/11/2010 | US20100286290 Enzyme activity assay using rolling circle amplification |
| 11/11/2010 | US20100286289 Chitosan-containing composition and production process of same |
| 11/11/2010 | US20100286288 Quarternization of the additive amino alkylmethacrylate copolymer e for improving permeability and solubility of pharmaceuticals |
| 11/11/2010 | US20100286287 Water-absorbing polymer structure with improved color stability |
| 11/11/2010 | US20100286286 Orally disintegrating tablet |
| 11/11/2010 | US20100286253 Method for treating ocular neovascularization |
| 11/11/2010 | US20100286205 Wound care formulation |
| 11/11/2010 | US20100286095 Novel use of a polyamine-depleted food composition for human or veterinary use, for preparing a therapeutic food product |
| 11/11/2010 | US20100286066 Alpha 1-Antitrypsin Compositions and Treatment Methods Using Such Compositions |
| 11/11/2010 | US20100286022 Edible and biocompatible metal-organic frameworks |
| 11/11/2010 | US20100285164 Orally Disintegrating Excipient |
| 11/11/2010 | US20100285142 Method Of Making Particles For Use In A Pharmaceutical Composition |
| 11/11/2010 | US20100285132 Immunotherapy compositions, method of making and method of use thereof |
| 11/11/2010 | US20100285029 Treatment of fungal infections with polyene or beta glucan synthase inhibitor anti-fungals combined with anti-hsp90 antibodies |
| 11/11/2010 | US20100284920 Uses of monoclonal antibody 8h9 |
| 11/11/2010 | US20100284913 Methods and compositions for studying, imaging, and treating pain |
| 11/11/2010 | DE102009019268A1 Perorally administrable solid drug, useful for the controlled release of active agent in gastrointestinal tract, comprises a porous matrix made of a material in which an active component is dissolved, emulsified, suspended or dispersed |
| 11/11/2010 | CA2761120A1 Uses of immunoconjugates targeting cd138 |
| 11/11/2010 | CA2761000A1 Composition for sustained drug delivery comprising geopolymeric binder |
| 11/11/2010 | CA2760945A1 Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same |
| 11/11/2010 | CA2760764A1 Multi-valent adjuvant display |
| 11/11/2010 | CA2760140A1 Topical solution formulations containing a corticosteroid and a cyclodextrin |
| 11/11/2010 | CA2758607A1 Porous silicon drug-eluting particles |
| 11/10/2010 | EP2248832A1 A g-csf conjugate modified by water-soluble polymer |
| 11/10/2010 | EP2248580A1 Method for preparation of aqueous emulsion using interfacially active organic compound as emulsifying agent |
| 11/10/2010 | EP2248518A1 Formulation for stabilizing proteins, which is free of mammalian excipients |
| 11/10/2010 | EP2248517A1 Concentrated mast cell stabilizing pharmaceutical formulations |
| 11/10/2010 | EP2247646A2 Fine powder of polyamide from renewable materials and method for making such powder |
| 11/10/2010 | EP2247620A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 11/10/2010 | EP2247605A1 Hydrophobic modified pres-derived peptides of hepatitis b virus (hbv) and their use as hbv and hdv entry inhibitors |
| 11/10/2010 | EP2247312A2 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 11/10/2010 | EP2247311A1 Compositions for delivery of cargo such as drugs proteins and/or genetic materials |
| 11/10/2010 | EP2247308A1 Adjuvant compositions comprising poly-ic and a cationic polymer |
| 11/10/2010 | EP2247307A1 Vaccine |
| 11/10/2010 | EP2247284A2 Process to minimize polymorphism |
| 11/10/2010 | EP2247282A1 Sustained release formulation comprising octreotide and three linear polylactide-co-glycolide polymers |
| 11/10/2010 | EP2073849B1 Methods and compositions for gene therapy |
| 11/10/2010 | EP1704160B1 Methods and compositions for identifying rna-binding proteins |
| 11/10/2010 | EP1631318B1 Magnetic nanoparticles linked to a ligand |
| 11/10/2010 | EP1527125B1 Porous beads and method of production thereof |
| 11/10/2010 | EP1460995B1 Transdermal transport of compounds |
| 11/10/2010 | EP1454950B1 Pullulan-containing powder, process for producing the same and use thereof |
| 11/10/2010 | EP1447082B1 Non-gelatinous capsules |
| 11/10/2010 | EP1153613B1 Percutaneous absorption preparations of compound having angiotensin ii receptor antagonism |
| 11/10/2010 | CN1973902B Anticancer medicine adriamycin composition with ginseng polyse as carrier and its preparation process |
| 11/10/2010 | CN1938006B Enteric coatings for orally ingestible substrates |
| 11/10/2010 | CN1921891B Growth factor-binding compounds connecting with Calixarene |
| 11/10/2010 | CN1917782B A drink containing ultrafine powder of ginseng and the method thereof |
| 11/10/2010 | CN1895676B Prodrug of taxol or polyene-taxol with carbowax as carrier |
| 11/10/2010 | CN1864665B Method for preparation of drug-encapsulating polymer micelle |
| 11/10/2010 | CN1861041B Temp-sensitive, slow-releasing gel used for local injection, and its preparation method |
| 11/10/2010 | CN1845742B Method of stabilizing diarylvinylene compound |
| 11/10/2010 | CN1799549B Process for preparing soybean isoflavone phospholipid composition |
| 11/10/2010 | CN1775946B Enhanced virus-mediated DNA transfer |
| 11/10/2010 | CN1708283B Skin preparations for external use |
| 11/10/2010 | CN1705494B Colon cleansing compositions |
| 11/10/2010 | CN101883765A Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same |
| 11/10/2010 | CN101883609A Rapid acting injectable insulin compositions |
| 11/10/2010 | CN101883588A High concentration antibody-containing liquid formulation |
| 11/10/2010 | CN101883559A Edible film |
| 11/10/2010 | CN101883557A Novel thermosensitive liposomes containing therapeutic agents |
| 11/10/2010 | CN101883556A Transdermal delivery system for hormones and steroids |
| 11/10/2010 | CN101883555A Intranasal compositions |
| 11/10/2010 | CN101880656A Agkistrodon halys venom thrombin and preparation method and application thereof |